Effect of high nucleated cell concentration on product viability and hematopoietic recovery in autologous transplantation
Transfusion2020Vol. 60(3), pp. 575–581
Citations Over Time
David Lin, Matthew Hiskey, Jane Huang, Cherie Nickerson, Desmond Saisitthidej, Andrea Bradford, Joshua Woodburn, Andrea Lius, Adam Skrzekut, Ellen Amy Tran, Rebecca Haley
Abstract
Our retrospective investigation provides further supporting evidence that HPC(A) products with cell concentration greater than 3 × 108 NC/mL did not show detrimental effects on the clinical outcomes in patients undergoing autologous PBSC transplantation.
Related Papers
- → Low Temperature Preservation of Mouse Lymphocytes with Dimethyl Sulfoxide(1964)75 cited
- → MECHANISM CONSIDERATIONS OF DIMETHYL SULFOXIDE (DMSO)-LENTICULAR CHANGES IN RABBITS(1971)18 cited
- → Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 years(2012)5 cited
- → CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol(1999)24 cited
- → OC.11.4 LONG TERM EFFICACY OF GRANULOCYTE-MONOCYTE-APHERESIS IN ULCERATIVE COLITIS. THE ITALIAN REGISTRY OF THERAPEUTIC APHERESIS(2014)